These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23235487)

  • 1. Altered fibrin clot properties in patients with premature peripheral artery disease.
    Okraska-Bylica A; Wilkosz T; Słowik L; Bazanek M; Konieczyńska M; Undas A
    Pol Arch Med Wewn; 2012; 122(12):608-15. PubMed ID: 23235487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans.
    Undas A; Nowakowski T; Cieśla-Dul M; Sadowski J
    Atherosclerosis; 2011 Apr; 215(2):481-6. PubMed ID: 21324459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
    Gronostaj K; Richter P; Nowak W; Undas A
    Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism.
    Owczarek D; Cibor D; Sałapa K; Głowacki MK; Mach T; Undas A
    Inflamm Bowel Dis; 2013 Nov; 19(12):2616-24. PubMed ID: 24108112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
    Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
    Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B; Gluszko P; Undas A
    Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
    Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
    PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered plasma fibrin clot properties are associated with in-stent thrombosis.
    Undas A; Zalewski J; Krochin M; Siudak Z; Sadowski M; Pregowski J; Dudek D; Janion M; Witkowski A; Zmudka K
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):276-82. PubMed ID: 19910643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia.
    Nowakowski T; Malinowski KP; Niżankowski R; Iwaniec T; Undas A
    J Thromb Thrombolysis; 2019 May; 47(4):540-549. PubMed ID: 30762155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new insight into retinal vein occlusion pathogenesis.
    Karska-Basta I; Kubicka-Trzaska A; Pogrzebielski A; Romanowska-Dixon B
    Klin Oczna; 2013; 115(4):269-74. PubMed ID: 24908915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
    Undas A; Slowik A; Wolkow P; Szczudlik A; Tracz W
    Thromb Res; 2010 Apr; 125(4):357-61. PubMed ID: 19942259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
    Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
    Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome.
    Celinska-Löwenhoff M; Zabczyk M; Iwaniec T; Plens K; Musial J; Undas A
    Rheumatology (Oxford); 2018 Aug; 57(8):1340-1349. PubMed ID: 29672756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties.
    Skuza AA; Polak M; Undas A
    J Thromb Thrombolysis; 2019 Jan; 47(1):8-15. PubMed ID: 30511257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes.
    Konieczyńska M; Bryk AH; Malinowski KP; Draga K; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1671-1678. PubMed ID: 28569923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
    Hooper JM; Stuijver DJ; Orme SM; van Zaane B; Hess K; Gerdes VE; Phoenix F; Rice P; Smith KA; Alzahrani SH; Standeven KF; Ajjan RA
    J Clin Endocrinol Metab; 2012 May; 97(5):1463-73. PubMed ID: 22378816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.